Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 1 | |
Hold | 3 | |
Sell | 3 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Enfusion Inc have a median target of 9.75, with a high estimate of 11.00 and a low estimate of 8.50. The median estimate represents a 2.63% increase from the last price of 9.50.
High | 15.8% | 11.00 |
Med | 2.6% | 9.75 |
Low | -10.5% | 8.50 |
Dividends in USD
Div growth (TTM) | -- |
---|
More ▼
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 10, 2025.
Average growth rate | +8.33% |
Average growth rate | -4.24% |
More ▼
Revenue history & estimates in USD
Average growth rate | +3.61% |
Average growth rate | +25.34% |
More ▼